Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 11 | -676K | 100% | $61.59 | -$41.7M |
Net | -11 | -676K | -100% | -$41.7M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Meridian Venture Partners II Lp | 10%+ Owner | $103M | Aug 16, 2023 | ||
Muthusamy Shanmugam | HEAD OF R&D, COO-NOVITIUM OPS, Director | $43.8M | -$26.9M | -38% | Jul 18, 2024 |
Nikhil Lalwani | PRESIDENT & CEO, Director | $22.6M | -$4.09M | -15.3% | Sep 8, 2024 |
Chad Gassert | Svp Corp. Dev. & Strategy | $15.4M | -$6.55M | -29.8% | Jul 1, 2024 |
Stephen P. Carey | Svp & Cfo | $10.3M | -$828K | -7.44% | Jun 4, 2024 |
James G. Marken | Svp Ops & Prod Dev | $7.98M | -$1.62M | -16.8% | Jun 7, 2024 |
Ori Gutwerg | Svp, Generics | $5.62M | -$200K | -3.44% | Jun 5, 2024 |
Christopher Mutz | Head Of Rare Disease | $5.13M | -$611K | -10.6% | May 21, 2024 |
Patrick D. Walsh | Director | $4.6M | May 21, 2024 | ||
Meredith Cook | Sr. Vp, General Counsel & Sec. | $3.22M | -$165K | -4.88% | Sep 13, 2024 |
Thomas Haughey | Director | $3.17M | May 21, 2024 | ||
Krista Davis | Svp, Chief Hr Officer | $2.81M | -$141K | -4.78% | Sep 12, 2024 |
Robert E. Brown JR | Director | $2.77M | Apr 27, 2022 | ||
Jeanne Thoma | Director | $2.5M | May 21, 2024 | ||
Thomas Rowland | Svp, Head Established Brands | $2.29M | Mar 28, 2024 | ||
David Nash | Director | $2.18M | May 23, 2023 | ||
Antonio R. Pera | Director | $1.91M | -$456K | -19.3% | May 21, 2024 |
Renee P. Tannenbaum | Director | $1.39M | -$128K | -8.4% | May 21, 2024 |
Matthew J. Leonard | Director | $739K | May 21, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|